Search
Search Constraints
You searched for: Author/Creator Czibere, BernadettLimit your search
- Czibere, Bernadett [remove] 1
- 616.994 1
- ASCT autologous stem-cell transplantation -- BP bendamustine-prednisone -- ClRd clarithromycin-lenalidomide-dexamethasone -- CPR cyclophosphamide-prednisone-lenalidomide -- CRD cyclophosphamide-lenalidomide-dexamethasone -- CrI credible interval -- CTD cyclophosphamide-thalidomide-dexamethasone -- D dexamethasone -- D-D dexamethasone → dexamethasone -- D-IFN dexamethasone-IFN alfa-2b -- Dara-Rd28 daratumumab-lenalidomide-dexamethasone -- Dara-VMP daratumumab-bortezomib-melphalan-prednisone -- ERd elotuzumab-lenalidomide-dexamethasone -- HDT-ASCT high-dose therapy and autologous stem cell transplantation -- ITD ixazomib-thalidomide-dexamethasone -- ITD-I ixazomib-thalidomide-dexamethasone → ixazomib -- I300CD-I ixazomib-300 mg cyclophosphamide-dexamethasone → ixazomib -- I400CD-I ixazomib-300 mg cyclophosphamide-dexamethasone → ixazomib -- IMiD immunomodulatory derivative -- KRd carfilzomib-lenalidomide-dexamethasone -- KMP carfilzomib-melphalan-prednisone -- MD melphalan-dexamethasone -- MM multiple myeloma -- MP melphalan-prednisone -- MPR melphalan-prednisone-lenalinomide -- MPR-R melphalan-prednisone-lenalinomide → lenalidomide -- MPT melphalan-prednisone-thalidomide -- MPT-T melphalan-prednisone-thalidomide → thalidomide -- NCCN National Comprehensive Cancer Network -- NMA network meta-analysis -- OS overall survival -- Pemb-Rd28 pembrolizumab-lenalidomide-dexamethasone -- PFS progression-free survival -- PI proteasome inhibitor -- RCT randomized controlled trial -- Rd28 lenalidomide-dexamethasone 28-day cycles -- Rd28−18 lenalidomide-dexamethasone 28-day cycles n = 18 -- SMVP siltuximab-bortezomib-melphalan-prednisone -- SUCRA surface under cumulative ranking -- TD thalidomide-dexamethasone -- TIE transplant-ineligible -- TIE-MM transplant- ineligible -- VAD vincristine doxorubicin, dexamethasone -- VD bortezomib-dexamethasone -- VMP bortezomib-melphalan-prednisone -- VMPT-VT bortezomib-melphalan-prednisone-thalidomide → bortezomib-thalidomide -- VTD bortezomib-thalidomide-dexamethasone 1
- Hematology -- Periodicals 1
- Multiple myeloma -- Transplant-ineligible -- Meta-analysis -- Survival -- First-line 1
- Oncology -- Periodicals 1